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ABSTRAK
Virilisasi akibat kelebihan hormon androgen yang terjadi pada wanita akan menimbulkan tanda-tanda 
seperti pembesaran klitoris, perubahan suara, tumbuhnya rambut di wajah dan tubuh yang menjadi ciri khas 
laki-laki. Virilisasi yang disebabkan oleh tumor ovarium tidak lebih dari 0,5% dari seluruh penyebab. Kami 
melaporkan kasus virilisasi akibat tumor sel Leydig pada ovarium kiri wanita usia 36 tahun. Kesalahan 
interpretasi, informasi medis yang saling bertentangan dan saran dari dokter sebelumnya membuat kebingungan 
dari pasien tersebut. Kami melakukan evaluasi diagnostik yang meliputi gambaran klinik, hormon, pencitraan, 
pemeriksaan patologi, molekuler serta pemeriksaan psikologi.
Pemeriksaan hormon menunjukkan kadar testosteron yang sangat tinggi. Adanya tumor pada ovarium 
terdeteksi dari pemeriksaan laparoskopi. Biopsi pada ovarium kiri dilakukan oleh karena pasien menolak 
dilakukan pengangkatan ovarium. Hasil pemeriksaan patologi menunjukkan tumor sel Leydig tanpa adanya tanda 
keganasan. Pengelolaan menjadi kurang optimal karena faktor sosial budaya yang menghambat walaupun telah 
dilakukan konseling secara mendalam. Tumor sel Leydig pada ovarium dicurigai apabila terjadi  virilisasi pada 
wanita usia reproduktif disertai peningkatan hormon androgen, massa ovarium pada pemeriksaan pencitraan dan 
dibuktikan dengan hasil biopsi. Hal ini penting sebelum memberikan saran maupun pengobatan kepada pasien.
Kata kunci: diagnostik work up, virilisasi, sel tumor Leydig.
ABSTRACT
Virilization due to hyperandrogenism in women causes male signs and symptoms such as swelling of the 
clitoris, deepening of the voice, facial hair and increase in body hair. Virilization is caused by less than 0.5% 
of all ovarian tumors. Here we report a case of virilizing Leydig cell tumor of the left ovary in a 36 year old 
woman. Misinterpretation of symptoms, conflicting medical information and advice from previous doctors had 
confused the patient. We performed a diagnostic evaluation including clinical, hormonal parameters, imaging, 
anatomical pathology examinations, and psychological assessment. 
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Blood analysis showed a high testosterone level. The presence of an ovarian tumor was confirmed by 
laparoscopy. Since the patient refused ovariectomy, a biopsy of the left ovary was performed. Pathology showed 
a Leydig cell tumor without histological signs of malignancy. In spite of extensive explanation and psychological 
counseling, cultural barriers prevented appropriate treatment. An ovarian Leydig cell tumor should always be 
considered for a woman in the reproductive age with symptoms of virilization. The diagnosis is suspected on 
the basis of an  ovarian mass on examination and further investigation and should be proven by biopsy.
Key words: diagnostic work up, virilization, Leydig cell tumor.
INTRODUCTION
Androgen excess is the most common 
endocrine disorder in reproductive-aged women, 
affecting approximately 7% of this population.1 
This results in ovulatory dysfunction and the 
development of androgenic features such as 
hirsutism, androgenic alopecia, acne, and, 
if extreme and prolonged, virilization of the 
genitalia.
Hyperandrogenism comprises  of  a 
heterogeneous group of disorders that exhibit a 
common phenotype. The most common causes 
include polycystic ovary syndrome (PCOS), 
defects of adrenal or ovarian steroidogenic 
enzymes, ovarian hyperthecosis and theca cell 
hyperplasia. Another reason is the presence 
of an androgen producing ovarian neoplasm, 
although these are rare and account for less than 
0.5% of all ovarian tumors. These tumors are 
composed entirely or predominantly of Leydig 
cells. A previous investigation showed that SRY-
independent SOX9 expression can be found in 
ovarian Sertoli-Leydig cell tumors although the 
exact mechanisms still remain obscure.2 Finally, 
spontaneous testosterone production might be 
caused by an activating mutation in the LH 
receptor (LHR).
Here we report a case of an androgen 
producing ovarian tumor in an adult woman. 
In addition, we described the psychosocial and 
cultural barriers that prevented appropriate 
treatment.
CASE ILLUSTRATION
History of Patient
A 36-year-old single woman presented at 
our outpatient clinic with complaints of fatigue, 
hirsutism and signs of marked virilization (Figure 
1). Menarche occurred at the age of 12 and she 
had regular cycles until the age of 28. After a 
period of 5 months of amenorrhea, she visited a 
gynecologist. Presuming the clinical diagnosis 
of PCOS, progestagen treatment was prescribed, 
which induced withdrawal bleedings. Since 
then, her periods remained under progestagen 
therapy. She reported that during the following 
3 years there she experienced progressive 
masculinization such as virilization, facial hair 
growth, deepening of her voice, and a prominent 
Adam’s apple. Her family history was negative 
for endocrinopathies.
Subsequently, she was referred to our center. 
Upon physical examination she was 152 cm 
tall and weighed 56 kg (BMI: 24.2). She had 
excessive pubic and abdominal hair (Ferriman-
Gallwey score 15). A male type beard was 
present; there was no acne. The breasts were 
atrophied (Tanner stage 3). The blood pressure 
varied between 110/70 and 200/110 mm Hg and 
pulse rate was 80 per minute. External genital 
examination showed an enlarged clitoris (2.5 
cm) and a normal female opening of the urethra, 
absence of fusion of labia majora and minora 
(Figure 1).
Figure 1. Enlargement clitoris and excessive pubic hair
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Hormonal analyses were performed, of 
which the results are shown in Table 1. Pelvic 
and abdominal ultrasonographic examination 
showed normal ovaries on both sides and a 
normal-sized uterus. The adrenal glands and 
kidneys were also normal.
hot spot region in exon 11 of the LHR gene, 
mutations of which can lead to constitutive 
activation of the LHR,  did not show a mutation. 
In conclusion the left ovary contained  a gonadal 
stromal tumor compatible with a Leydig cell 
tumor lacking histological signs of malignancy.
Luteinizing Hormone Receptor Analysis
Analysis of the hot spot region in exon 11 of 
the LHR gene, mutations of which can lead to 
constitutive activation of the LHR,  did not show 
a mutation (Figure 3).
Table 1. Results of hormonal evaluation of the patient
Hormone* unit patient Reference ranges
   women**
LH IU/l 12.3 1.5-8.0
FSH IU/l 8.1 1.0-8.0
Progesterone nmol/l 2.0 <0.5-3.0
17-hydroxyprogesterone nmol/l 9.9 <0.5-2.0
Androstenedione nmol/l 18.0 2.0-10.0
Testosterone nmol/l 59.5 0.5-3.0
DHEA sulfate mmol/l 3.8 1.0-10.0
Cortisol nmol/l 191 200-800
AMH mg/l 0.9 0.5-7.0
* DHEA: dehydroepiandrosterone; AMH: anti-Müllerian 
Hormone; LH: Luteinizing Hormone; FSH: Follicle 
Stimulating Hormone, ** Values during the first week of 
the menstrual cycle
Hormonal results suggested an androgen 
producing tumor originating from the ovary 
although this was not confirmed by ultrasound. 
Therefore, abdominal laparoscopy was 
undertaken. A biopsy was taken of the left ovary, 
which contained a structure with the appearance 
of a polycystic tumor (lesion size 4x3.2x3.4cm). 
The right ovary did not show macroscopic 
abnormalities (size:3.3x2.8x1.5 cm).
Histopathological Examination 
Histopathological examination demonstrated 
the presence of an ovarian tumor. The tissue 
consisted of small epithelioid cells with a pale 
eosinophilic, well-demarcated cytoplasm and 
small nuclei with dark chromatin. No atypical 
cells or mitotic figures were noticed. Reinke 
crystals were not found in the specimen. The 
tumor cells stained positive for the inhibin 
a-subunit and LHR, markers for Leydig cells, 
and negative for SOX9, a marker for Sertoli 
cells (Figure 2). These findings are consistent 
with a gonadal stromal tumor, and specifically 
for a Leydig cell tumor. No histological signs 
of malignancy were identified. Analysis of the 
Figure 2. Ovary with a Leydig cell tumor. H&E staining 
revealed ovarian structures with gonadal stromal tumor 
compatible with Leydig cells (A1-2) (black arrow). Positive 
inhibin α-subunit was staining (B1-2); Negative for SOX 9 
staining (C1-2). Magnification: left panel x 100, right panel 
x 400. Luteinizing hormone receptor (LHR) presence was 
detected by immunohistochemistry. Brown staining in 
cytoplasm shown in cord-stromal of the ovary. Magnifications 
were x 100 (D1) and x 400 (D2)
Figure 3. Sequence of luteinizing hormone receptor gene on 
exon 11 from Leydig cell tumor coding for Phe576, Thr577, 
Asp578 and Phe 579 showing a wild type receptor.
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Psychosocial Aspects
The patient came from a middle class 
Javanese family and obtained a university 
degree. The virilization of her body caused her 
a lot of distress. She consulted several medical 
doctors and beauticians who gave her conflicting 
advice. All treatments she underwent had been 
unsuccessful as she virilized progressively. 
After we found the cause of her virilization, we 
informed her about her condition and the nature 
of the ovarian tumor and proposed ovariectomy. 
She refused treatment, as she feared to become 
infertile after treatment. She particularly feared 
the social consequences of being an infertile 
woman. As an alternative, hormonal replacement 
therapy was proposed, but she refused. In the past 
she had already experienced that progestagen 
therapy could not stop virilization. One of the 
doctors she had consulted before had informed 
her that a pregnancy would cure her disease and 
she preferred to follow this advice. She kept 
looking for a partner, but remained unsuccessful. 
Psychological counselling was offered to allow 
her to express her worries and to help her 
understand her condition and its consequences, 
the necessity for treatment and the rationale 
behind the proposed treatments. She discussed 
the pressure she felt to marry and have children. 
She had already turned 36, whereas most Javanese 
women will marry and have their first child 
between age 20 and 30. It was expected that family 
support could take away some of the experienced 
shame and distress and proposed to establish 
such support by informing the family about her 
condition. However, this was unsuccessful. She 
told that she had already informed her family 
and disliked subsequent discussions. No signs 
of mental disorder and symptoms of depression 
were present. Her openness to discuss the impact 
of her condition on her life and her maintained 
confidence in cure by getting pregnant clarified 
her resistant attitude.
DISCUSSION
Systematic investigations in adult women 
with virilization are necessary to establish the 
right diagnosis. According to the literature, 
clinical signs of virilization should be confirmed 
by hormonal and ultrasound examinations.3 
Laparoscopy followed by biopsy is necessary 
to obtain a hystopathological description and 
diagnosis.
In this patient, symptoms of hyperandrogenism 
were the main initial clinical features. The signs 
of hirsutism and amenorrhea appeared at the age 
of 28 years within a 5 month period. Before, she 
had regular menses and pubertal development 
had also been normal. Initially a diagnosis of 
PCOS was considered and indeed hormonal 
treatment resulted in regular bleedings, which 
may have convinced the patient that she was 
fertile. However the progressive virilization even 
under hormonal treatment had raised suspicion 
for an androgen-secreting tumor.  The hormonal 
data suggested an androgen-producing tumor of 
the ovary since serum hormone assay showed 
increased levels of 17-hydroxyprogesterone and 
androstenedione and extremely high levels of 
testosterone with normal levels of the adrenal 
steroids cortisol, and dehydroepiandrosterone 
sulfate. Her bodily changes such as signs of 
virilization, including severe hirsutism, frontal 
balding, clitoromegaly, increased libido, altered 
body fat, increased muscle mass, breast atrophy, 
deepening of voice, and pustular acne were in 
accordance with hormonal data are common 
symptoms in Leydig cell ovarian tumors.4 
Estrogenic manifestations, such as irregular 
menses have also been reported. Symptoms and 
signs may present gradually with the onset of 
symptoms ranging from 5 to 7 years prior the 
diagnosis.5 This patient is exceptionally young 
as the mean age of women with a Leydig cell 
tumor is 58 years.4
Sex cord-stromal tumors are known as 
the most common androgen-secreting ovarian 
tumors, representing less than 0,5% of all ovarian 
neoplasms. The histological classification of 
ovarian tumors conducted by the World Health 
Organization categorize sex cord tumors as 
granulosa-theca cell stromal tumors, Sertoli-
stromal cell tumors, sex cord tumor with annular 
tubules, gynandroblastoma, unclassified, and 
steroid cell tumors. About 15% to 20% of steroid 
cell tumors could be attributed to Leydig cell 
tumors.
Interestingly whereas Leydig cell tumors are 
usually benign histo-pathologically, these tumors 
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can behave in a clinically malignant fashion.6 
About 20% of patients develop metastatic lesions 
usually within the peritoneal cavity, and rarely 
at distant sites.7 Therefore, early treatment is 
necessary to prevent tumor to get worse.
The appearance of a virilizing tumor on 
radiological imaging depends on the type of 
tumor. Characteristic of steroid cell tumors 
are typically small nodules less than 3 cm and 
unilateral.8 These tumors show a heterogeneous 
solid mass with internal areas of intracellular lipid 
and may be difficult to identify on radiological 
imaging, in part because they are isoechoic to the 
uterus on ultrasound. This may be the reason why 
no abnormality of the ovaries was found during 
ultrasound examination of our patient. CT or MRI 
was not done because of financial limitations.
In view of patient’s age and nulliparity, 
unilateral oophorectomy was offered as the first 
therapeutic option. Her refusal worsened her 
medical condition. Her decision to decline the 
given advice was related to the psychological 
mechanisms that will be triggered in case the 
offered cure is not congruent with the patient’s 
beliefs and also includes unfavorable social 
consequences.9,10 For young adult females, loss 
of fertility involves a social disadvantage. The 
patient made clear that she considered her ovaries 
as the only female part of her body that had been 
left and removal of even one ovary would mean 
taking away her femininity and everything that 
made her life worth to live. Her refusal for further 
discussion about treatment created a dilemma 
based on the respect for the patient’s right on 
the one hand, but the risk of further progression 
of the tumor on the other. In spite of efforts for 
additional appointments to discuss the possibility 
of ovariectomy, no changes in her opinion 
occurred. Therefore it is expected that over the 
years, virilization and weight gain will become 
more prominent. Androgen excess in women 
may lead to social withdrawal or even social 
phobia which will normalize after treatment.5,11 
However, in our patient, no signs of anxiety or 
depression were found.
CONCLUSION
This case report confirms that virilization in 
women should be investigated systematically and 
comprehensively. The diagnosis of Leydig cell 
tumor is made using clinical parameters such as 
amenorrhea, signs of virilization, and high serum 
testosterone levels and subsequently the finding 
of an ovarian mass on imaging. A diagnostic 
laparoscopy is indicated to confirm the diagnosis. 
Androgen secreting tumors, especially Leydig 
cell tumors of the ovary, should be considered 
among disorders causing virilization in women 
at reproductive age. What can be learned 
from this case? Even after comprehensive 
explanation and psychosocial counseling, 
cultural barriers prevented appropriate treatment. 
Social and community support is essential in the 
management of this patient.
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